Brief: BioCryst To Acquire Astria Therapeutics, Strengthening Presence In Hae, Transforming Growth Profile

BioCryst Pharmaceuticals

14/10/2025 12:16

Oct 14 (Reuters) - Astria Therapeutics Inc ATXS.O:

BIOCRYST TO ACQUIRE ASTRIA THERAPEUTICS, STRENGTHENING PRESENCE IN HAE, TRANSFORMING GROWTH PROFILE

BIOCRYST PHARMACEUTICALS- DEAL VALUED AT $13.00 PER ASTRIA SHARE, $700 MILLION ENTERPRISE VALUE

ASTRIA THERAPEUTICS INC - BIOCRYST TO PAY $8.55 CASH AND 0.59 SHARES PER ASTRIA SHARE

ASTRIA THERAPEUTICS INC - BIOCRYST ENTERS $550 MILLION FINANCING FACILITY WITH BLACKSTONE

ASTRIA THERAPEUTICS INC: EXPECTS CASH PORTION OF DEAL CONSIDERATION TO BE FUNDED WITH CASH ON HAND & PART OF BLACKSTONE FACILITY

Source text: ID:nBw4gdxGBa

Further company coverage: ATXS.O

 ((Reuters.Briefs@thomsonreuters.com;))